当前位置: 首页 > 期刊 > 《中国当代医药》 > 2011年第12期
编号:12076402
Aβ的神经毒性及治疗(1)
http://www.100md.com 2011年4月25日 《中国当代医药》 2011年第12期
     [摘要] Aβ(β-amyloid peptides,Aβ)是阿尔茨海默症(Alzheimer's disease,AD)发病过程中的核心因子。随着研究的逐渐深入,越来越多的证据表明Aβ在AD的发生、发展中起到主导作用。本综述主要针对Aβ的神经毒性及其复杂的分子机制展开叙述,而后同时就其神经毒性机制展开研究两大类治疗药物。

    [关键词] β-淀粉样蛋白;阿尔茨海默症;神经毒性;药物治疗

    [中图分类号] R74[文献标识码]A [文章编号]1674-4721(2011)04(c)-021-02

    The neurotoxicity and treatment of Aβ

    JIANG Shuyi1, MAO Fengju1, LI Xingqiang1, LAI Hong2

    1.Seven-year System,China Medical University, Liaoning Province, Shenyang 110001, China; 2.Anatomical Staff Room, China Medical University, Liaoning Province, Shenyang 110001, China

    [Abstract] Aβ(β-amyloid peptides, Aβ) is the core factor of the developing progress of Alzheimer's disease(AD). As the study deepened, more and more data indicates that Aβ plays a dominant role in the occurrence and development of AD. The former part of this summary mainly focuses on the neurotoxicity and the complexmolecular mechanism of Aβ. The posterior discuss the research results of two groups of drugs.

    [Key words] β-amyloid peptides; Alzheimer's disease; Neurotoxicity; Pharmacological functions

    阿尔茨海默症(Alzheimer's disease ......
1 2下一页

您现在查看是摘要页,全文长 4523 字符